[1] |
LIU dong, SU Kang-le, ZHANG Cui-jie, ZHAI Ya-ling, LI Fang-hua.
Relationship between positive expression of HBAg in renal tubules and prognosis of renal function damage associated with hepatitis B virus
[J]. Chinese Hepatolgy, 2020, 25(4): 372-374.
|
[2] |
GAO Peng-bin, ZHENG Huan-wei, ZHAO Xiao-yan, WANG De-hua, QIN Hao, MENG Ming-hui, ZHANG Jian-ji, YAN Shuang-huan.
The clinical characteristics and prognosis of patients with HBV-ACLF treated by internal medicine
[J]. Chinese Hepatolgy, 2020, 25(4): 375-378.
|
[3] |
ZHAO Meng, CHEN Ming, WANG Li, HIU Sun-yi.
Retrospective analysis of clinical characteristics and prognosis of children with autoimmune hepatitis
[J]. Chinese Hepatolgy, 2020, 25(4): 379-381.
|
[4] |
WANG Yu, XU Da-feng, ZHOU Kai-lun, WU Jin-cai, DING Yi-chao, GU Hai-qiang, XIE Ming-wei, LIN Ming-hua..
Dynamic changes of TLR4 and intestinal flora in the progression of primary liver cancer and its relationship with prognosis
[J]. Chinese Hepatolgy, 2020, 25(3): 273-276.
|
[5] |
WANG Jian-ye, ZHAO Zhi-cong, HOU jia-jie, XIA Qiang.
Expression of CCL23 in hepatocellular carcinoma and its effect on prognosis
[J]. Chinese Hepatolgy, 2019, 24(4): 368-372.
|
[6] |
HAN Lin, YANG Zhao, LIANG Qing-sheng, HUANG Ang, SUN Ying, ZOU Zheng-sheng.
Clinical features of 100 patients with drug-induced liver failure
[J]. Chinese Hepatolgy, 2019, 24(3): 229-233.
|
[7] |
HE Ting-ting, ZHONG Xue-wen, ZHANG Ning, BAI Yun-feng, ZHOU Kun, ZHOU Chao, WANG Yao, GONG Man.
Prospective clinical study of 187 cases with liver damage caused by Chinese herbal medicine and its preparations
[J]. Chinese Hepatolgy, 2018, 23(8): 666-669.
|
[8] |
AN Bao-yan, WANG Yun, XIANG Xiao-gang, CHEN Li-wen, CAO Zhu-jun, YAN Lei, DING Ye-zhou, TANG Wei-liang, LIN Lan-yi, ZHU Chuan-wu, XIE Qing, WANG Hui.
The effects of nucleos(t)ide analogues treatment on prognosis of patients with chronic hepatitis B-related hepatocellular carcinoma
[J]. Chinese Hepatolgy, 2018, 23(4): 294-296.
|
[9] |
YIN Wei, LI Cheng-zhong, ZOU Duo-wu.
Influence of liver function on the outcomes and prognosis of acute kidney injury in liver cirrhosis and liver failure patients
[J]. Chinese Hepatolgy, 2018, 23(4): 297-301.
|
[10] |
KAN Yan-ting, YANG Yong-feng.
Serum thyroid hormones in acute on chronic liver failure patients and its correlation with prognosis
[J]. Chinese Hepatolgy, 2018, 23(4): 305-306.
|
[11] |
YIN Wei, LI Cheng-zhong, ZOU Duo-wu.
Therapeutic response and prognosis under the new criteria (ICA2015) of acute kidney injury in cirrhosis patients and influencing factors.
[J]. Chinese Hepatolgy, 2018, 23(3): 201-205.
|
[12] |
WU Xu-bo, CHANG Qi-meng, WANG Jian-fa, HU Zhi-qiu, SHEN Xiao-dong, ZHANG Zi-ping..
Expression of chemokine ligand-18 in hepatocellular carcinoma and its influence on the clinicopathological features and prognosis
[J]. Chinese Hepatolgy, 2018, 23(2): 125-127.
|
[13] |
DING Jian-bo, LI Xiu-hui, GOU Chun-yan, WANG Xiao-jun, HAO Xin-jie, WANG Xian-bo..
Prognostic value of the model for end-stage liver disease score for patients with severe chronic hepatitis B
[J]. Chinese Hepatolgy, 2018, 23(10): 868-869.
|
[14] |
SHI Dong-mei, XIANG Xiao-gang, WANG Xiao-lin, XIE Qing.
Risk factors for incidence and prognosis of acute kidney injury in hospitalized patients with chronic liver diseases
[J]. Chinese Hepatolgy, 2017, 22(3): 200-204.
|
[15] |
LU Meng-meng,ZHOU Xin-min.
Prognostic value of combined serum cystatin C and total bilirubin in patients with acute-on-chronic liver failure
[J]. Chinese Hepatolgy, 2017, 22(3): 205-209.
|